Earnings & Reporting

As Melco Resorts prepares its 2025 results, investors watch for signs of Macau's sustained recovery and the payoff from its bold global expansion.

For its tenth straight Games, Technogym will equip Milano Cortina 2026 with AI-driven gear, cementing its legacy as the force behind athletic excellence.

The investment giant posted a record $129 billion in annual fundraising, but a slight miss on quarterly earnings sent its stock tumbling.

AEIS declares its quarterly dividend, signaling deep financial stability and strategic confidence fueled by explosive growth in key tech sectors.

The South Korean tobacco giant hits record revenue as its international strategy pays off, while it diversifies into nicotine pouches for future growth.

Canfor Pulp and Canfor Corp prepare for a critical joint earnings call on March 6 after a year of steep losses and severe market headwinds.

DHI Group announces a $10M stock buyback, a bold move showing faith in its strategy as it navigates a complex, AI-driven tech recruitment landscape.

A new report reveals a startling contradiction: while HR feels empowered, 62% admit their own outdated practices are creating a self-inflicted talent shortage.

Bitcoin miner CleanSpark makes a massive pivot, securing a 600MW Texas site to power the AI boom, diversifying beyond the volatile crypto market.

With a fresh capital infusion extending its runway into 2027, GRI Bio pushes ahead with promising clinical data for its IPF and autoimmune disease pipeline.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

Aethlon Medical's upcoming Q3 report puts its finances under a microscope as investors weigh a tight cash runway against progress on its Hemopurifier device.

A powerful new genomic tool is turning genetic doubt into diagnostic certainty, helping thousands of patients understand their true hereditary cancer risk.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

Superior Health's acquisition of Pulse Home Health, backed by private equity, signals a major shift in Louisiana's booming home health and hospice market.

The firm's assets grew on market gains, but significant client outflows and shrinking fees triggered a sharp stock drop, revealing key industry pressures.

A landmark survey reveals a massive capital rotation as 96% of institutions chase AI and 81% move to private markets to navigate a fragmenting world.

As Crown Crafts preps its Q3 earnings, investors watch to see if strategic shifts can overcome financial pressures in the competitive juvenile products market.

Markets are calm, but concerns over US Federal Reserve independence add a new layer of risk to global trade, threatening borrowing costs and stability.